Treating EGFR Patients After Tarceva Stops Working

Treating EGFR Patients After Tarceva Stops Working

Da: GRACEcast
0 0 6 anni fa
Tarceva (erlotinib) has greatly helped EGFR positive lung cancer patients, but eventually it stops working. Dr. Jonathan Goldman of UCLA Jonsson Comprehensive Cancer Center talks about the next generation EGFR inhibitors that may soon become available. February 2014.

Seguici su Facebook